Zusammenfassung
Die 9. Konferenz der Internationalen Working Group on Tick-Borne Encephalitis (ISW TBE) behandelte das Thema "FSME: von der Epidemiologie zu den Impfempfehlungen 2007, Neue Themen – beste Umsetzungen". In den letzten 3 Jahrzehnten ist die FSME in Europa und anderen Teilen der Welt zunehmend zu einem Problem der öffentlichen Gesundheit geworden. Zwischen 1974 und 2003 hat die Inzidenz der Hospitalisationen um mehr als 400 % zugenommen, einzige Ausnahme dieses Trends ist Österreich. Diese Zunahme ist das Ergebnis eines komplexen Zusammenspiels von sozialen, ökonomischen, politischen, ökologischen und klimatischen Faktoren, wobei der Einfluss der einzelnen Faktoren nicht leicht quantifizierbar ist. Wichtige zukünftige Themen und Projekte der Gruppe wurden identifiziert, wie etwa die Implementierung einer standardisierten Definition eines FSME Falles, verstärktes Bewusstsein gegenüber der Problematik "FSME und der Reisende", Informationen zu Möglichkeiten einer Schnellimmunisierung, Erhöhung der Durchimpfungsraten in endemischen Ländern und die Publikation von Krankheitsfällen.
Summary
The 9th annual meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW TBE) was entitled "Tick-borne encephalitis: from epidemiology to vaccination recommendations in 2007, new issues – best practices". Over the past three decades, TBE has become a growing public health challenge in Europe and other parts of the world. Between 1974 and 2003, the number of reported clinical TBE cases increased by an appalling 400 %, the only exception having been Austria. This increase is the result of a complex interplay of social, economic, political, ecological and climatic factors, the relative weight of which is not easily quantifiable. Important projects and issues for the future work of the ISW TBE have been identified, such as implementing a standardized TBE case definition, raising awareness of TBE among travellers, availability of rapid immunization schemes, increasing vaccination rates in endemic countries, and publishing information on TBE cases.
This is a preview of subscription content, log in via an institution to check access.
References
Kunze U, Asokliene L, Bektimirov T, Busse A, Chmelik V, Heinz FX, Hingst V, Kadar F, Kaiser R, Kimmig P, Kraigher A, Krech T, Linquist L, Lucenko I, Rosenfeldt V, Ruscio M, Sandell B, Salzer H, Strle F, Suss J, Zilmer K, Mutz I (2004) Tick-Borne encephalitis in childhood – Consensus 2004. Wien Med Wochenschr 154: 242–245
Kunze U, Baumhackl U, Bretschneider R, Chmelik V, Grubeck-Loebenstein B, Haglund M, Heinz F, Kaiser R, Kimmig P, Kunz C, Kunze M, Mickiene A, Misic-Majerus L, Randolph S, Rieke B, Stefanoff P, Suss J, Wimmer R; International Scientific Working Group on Tick-borne encephalitis (2005) The Golden Agers and Tick-borne encephalitis. Conference Report and Position Paper of the International Scientific Working Group on Tick-borne encephalitis. Wien Med Wochenschr 155: 289–294
Kunze U and the ISW TBE (2006) Tick-borne encephalitis – a European health challenge. Conference report of the 8th meeting of the International Scientific Working Group on Tick-borne Encephalitis (ISW TBE). Wien Med Wochenschr 156: 376–378
World Health Organization (2004) The vector-borne human infections of Europe. WHO 37–49
Süss J (2003) Epidemiology and ecology of TBE relevant to the production of effective vaccines. Vaccine 21: 19–35
Süss J (2005) Zunehmende Verbreitung der Frühsommer-Meningoenzephalitis in Europa. Dtsch Med Wschr 130: 1397–1400
Rendi-Wagner P (2004) Risk and prevention of tick-borne encephalitis in travelers. J Travel Med 11: 307–312
Fessl GFK (2006) TBE vaccination in Austria: Results of a representative survey of the Austrian population. Fessl Gfk Institute, Vienna, Austria
Kunz C (2003) TBE vaccination and the Austrian experience. Vaccine 21: 50–55
Randolph S (2004) Evidence that climate change has caused "emergence" of Tick-borne disease in Europe? Int J Med Microbiol 293: 5–15
Randolph S (2002) Predicting the risk of tick-borne diseases. Int J Med Microbiol 291: 6–10
Haglund M (2002) Occurrence of TBE in areas previously considered being non-endemic: Scandinavian data generate an international study by the International Scientific Working Group for TBE (ISW TBE). Int J Med Microbiol 291: 50–54
Skarpaas T, Ljostad U, Sundoy A (2004) The first human cases of tick-borne encephalitis in Norway. Emerg Infect Dis 12: 2241–2243
De Valliere S, Cometta A, Zimmermann H, Vaudaux B, Meylan P (2006) Evidence of new foci of tick-borne encephalitis in the French speaking part of Switzerland. Rev Med Suisse 80: 2191–2194
Fessl GFK (2006) TBE vaccination rate study. Health Care Austria
Loew-Baselli A, Poellerbauer EM, Fritsch S et al (2006) Immunogenicity and safety of FSME-IMMUN 0.5 ml using a rapid immunization schedule. Int J Med Microbiol 296: 213–214
Beran J, Douda P, Gniel D, Zent O (2004) Long-term immunity after vaccination against tick-borne endephalitis with Encepur using the rapid vaccination schedule. Int J Med Microbiol 293: 130–133
Gritsun TS, Lashkevich VA, Gould EA (2003) Tick-borne encephalitis. Antiviral Res 57: 129–146
Günther G, Haglund M (2005) Tick-Borne Encephalopathies: Epidemiology, Diagnosis, Treatment and Prevention. CNS Drugs 12: 1009–1032
Marth E, Kleinhappl B (2001) Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination. Vaccine 20: 532–537
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kunze, U. Tick-borne encephalitis: from epidemiology to vaccination recommendations in 2007 New issues – best practices. Wien Med Wochenschr 157, 228–232 (2007). https://doi.org/10.1007/s10354-007-0424-8
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10354-007-0424-8